News Release – 2015 | News Release | Hisamitsu Pharmaceutical co.,inc.

2015.12.11: Notification of listing on the NHI drug price standard and marketing of MOHRUS® PAP XR 120mg, a topical analgesic and anti-inflammatory product

2015.12.09: Notification of the commencement of the Phase III clinical study of HP-3060 in Japan (a transdermal drug for the treatment of allergic rhinitis)

2015.10.09: FY02/2016 Q2 Results Earnings Release Presentation

2015.09.30: Notice of Revision of Financial Forecast

2015.09.30: Noven Pharmaceuticals, Inc. press release :Noven announces favorable decisions in the inter partes reviews challenging Novartis’ Exelon® Patch patents

2015.09.09: Notification of acquisition result and acquisition end of company’s own shares.

2015.08.28: Notification o f the commencement of the Phase II clinical study of HP-3150 Japan for ‘Lower back pain'(an analgesic transdermal drug containing NSAIDs )

2015.08.25: Notice concerning the decision of matters relating to acquisition company’s own shares.

2015.08.17: Notification of the Marketing Approval of MOHRUS®PAP XR a topical analgesic and anti-inflammatory product

2015.07.27: Notice Concerning Finalization of Details of Issuance of Stock Options as Compensation

2015.07.10: FY02/2016 Q1 Results Earnings Release Presentation

2015.07.10: Notification o f the commencement of the Phase II / III clinical study of HP-3150 Japan (an analgesic transdermal drug containing NSAIDs )

2015.07.10: Notice Concerning Issuance of Stock Options as Compensation

2015.04.14: Notification on the commencement of a Phase III clinical study of HP-3000 in Japan (a transdermal drug for the treatment of Parkinson’s disease)

2015.04.08: Announcement of Dividend Surplus in the Fiscal Year Ended February 2015 (113th Fiscal Year)

2015.04.08: Notice Concerning Partial Amendment of the Articles Incorporation

2015.04.08: Notice Concerning Abolition of Directors’ Retirement Benefit System and Granting of Stock Options as Compensation

2015.04.08: FY02/2015 Q4 Results Earnings Release Presentation

2015.03.23: Noven Pharmaceuticals, Inc. press release :Noven files patent infringement lawsuit against Actavis

2015.01.09: FY02/2015 Q3 Results Earnings Release Presentation